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ScienceDirectThe methylotrophic yeast Pichia pastoris is a widely used
recombinant expression host. P. pastoris combines the
advantages of ease of use, relatively rapid expression times
and low cost with eukaryotic co-translational and post-
translational processing systems and lipid composition. The
suitability of P. pastoris for high density controlled culture in
bioreactors means large amounts of protein can be obtained
from small culture volumes. This review details the key features
of P. pastoris, which have made it a particularly useful system
for the production of membrane proteins, including receptors,
channels and transporters, for structural studies. In addition,
this review provides an overview of all the constructs and cell
strains used to produce membrane proteins, which have
yielded high resolution structures.
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Introduction
The number of membrane protein structures has signif-
icantly increased in recent years, due in part at least, to
the development of a range of novel methodologies to
stabilise membrane proteins in solution [1]. However
our understanding of eukaryotic membrane proteins in
particular remains somewhat limited. One of the key
issues associated with eukaryotic membrane proteins is
the difficulty in expressing the significant amounts of
material required for structural biology. Eukaryotic
membrane proteins have specific co-translational and
post-translational processing and membrane lipid
requirements meaning that bacterial expression systems
are often unsuitable. The higher eukaryotic insect cell
based systems have an excellent track record for struc-
tural studies of GPCRs [2] although are much
more expensive and time-consuming than the bacterial
systems.www.sciencedirect.com A good middle-ground is achieved with the yeast expres-
sion systems which combine the advantages of ease of
manipulation and low cost of production with eukaryotic
protein processing. The two major yeast expression sys-
tems are Saccharomyces cerevisiae and Pichia pastoris. The
bakers yeast, S. cerevisiae, has a good track record with
respect to heterologous production of membrane protein
for structural studies (http//blanco.biomol.uci.edu/
mpstruc/). Some recent examples include the PiPT high
affinity phosphate transporter from the fungus, Pirifor-
mospora indica [3] expressed with N and C-terminal
FLAG and His tags, and the NRT1.1 nitrate transporter
from the model plant Arabidopsis thaliana [4] expressed as
a fusion protein with a C-terminal GFP-His8 tag [5].
However markedly better success has been achieved with
membrane proteins heterologously produced in P. pastoris
(http//blanco.biomol.uci.edu/mpstruc, Table 1 with exam-
ple structures in Figure 2). The aim of this review is to
provide a brief overview to the key features of the P. pastoris
expression system, with particular emphasis on the success-
ful examples of eukaryotic membrane proteins produced for
structural studies, using this system. It is hoped that this will
provide a useful starting point for researchers embarking on
membrane protein expression studies.
General features of the P. pastoris expression
system
P. pastoris is a methylotrophic yeast, able to utilise meth-
anol as the sole carbon source. There are a comparatively
limited number of vectors for P. pastoris expression but
the most widely used incorporate the very strong, induc-
ible AOX1 promoter. This promoter controls expression of
genes central to the metabolism of methanol, AOX1 and
AOX2. The AOX1 promoter is repressed in the presence of
glucose or glycerol but strongly upregulated in the pres-
ence of methanol, making it a relatively tightly controlled
expression system. However, recent research has identi-
fied protein expression occurring during the pre-induc-
tion phase in cultures grown in bioreactors but not in
shaker flasks indicating that the promoter is leaky under
certain conditions [6].
The P. pastoris vectors usually integrate into the host cell
genome to produce a stably expressing clone. It is not
possible to control the number of copies which integrate
and so the optimal clone must be experimentally deter-
mined. Copy number can be easily estimated through
colony screening in the presence of increasing concentra-
tions of antibiotic [7] although other methods including
real time PCR are also available [8]. However, higherCurrent Opinion in Structural Biology 2015, 32:9–17
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Table 1
Membrane protein structures obtained from protein expressed in P. pastoris.
Protein Source organism Expression
vector
Expression
strain
Genetic modificationsa Extra sequences PDB
Accession
Code and
reference
Membrane associated and membrane bound enzymes
Monoamine oxidase B Homo sapiens pPIC3.5K GS115/KM71 No tag 1GOS, [32]
1OJA, [33]
Monoamine oxidase A Homo sapiens pPIC9K KM71 No tag 2BXR, [34]
Leukotriene LTC4
synthase
Homo sapiens pPICZ KM71H N-terminal 6His tag 2UUH, [51]
4JCZ, 4JRZ,
4J7T, 4J7Y,
[52]
G-protein coupled receptors
Adenosine A2A
receptor
Homo sapiens pPIC9K SMD1163 Codon optimised,
C-terminal truncation,
mutated to remove N-
linked glycosylation site
Alpha factor signal
sequence,
N-terminal FLAG tag,
C-terminal 10His
3VG9, [21]
Histamine H1
receptor
Homo sapiens pPIC9K SMD1163 Codon optimised,
mutated to remove
N-linked glycosylation
sites, N-terminal
truncation, insertion of
sequence encoding T4
lysozyme into the third
intracellular loop
C-terminal GFP-8His 3RZE, [17]
Ion channels
Two-pore domain
potassium
channel K2P1.1
Homo sapiens pPICZ SMD1163 N and C terminal
truncation, mutated to
removed N-linked
glycosylation site and
prevent non-specific
disulphide bridge
formation
PreScission
cleavage site, C-
terminal GFP-His8
3UKM, [28]
Two-pore domain
potassium
channel K2P4.1
Homo sapiens pPICZ SMD1163 Codon optimised,
mutated to remove
N-linked glycosylation
sites, C-terminal
truncation
PreScission
cleavage site,
C-terminal GFP-His8
3UM7, [16]
4I9W, [38]
Kv1.2 voltage gated
potassium channel
Rattus norvegicus pPICZ SMD1163 Mutated to remove
glycosylation sites
N-terminal 8His tag
followed by TEV
cleavage site
2A79, [53]
Kv1.2 voltage gated
potassium channel
Rattus norvegicus 3LUT, [54]
Kir2.2 inward rectifier
potassium channel
Gallus gallus pPICZ SMD1163 N and C-terminally
truncated
C-terminal
PreScission
protease cleavage
site followed by GFP
and a 1D4 antibody
recognition site
3JYC, [55]
3SPI, [56]
Kv1.2/Kv2.1 voltage
gated potassium
channel chimera
Rattus norvegicus pPICZ SMD1163b Mutated to remove
N-linked glycosylation
sites and reduce
formation of non-
specific disulphide
bonds
N-terminal 10His tag
followed by a
Thrombin protease
cleavage site
2R9R, [25]
3LNM, [57]
GIRK2 (Kir 3.2)
G-protein gated
potassium channel
Mus musculus pPICZ SMD1163 N and C-terminally
truncated
C-terminal
PreScission
protease cleavage
site followed by GFP
and a 10His tag
3SYO, [22]
4KFM, [58]
Current Opinion in Structural Biology 2015, 32:9–17 www.sciencedirect.com
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Table 1 (Continued )
Protein Source organism Expression
vector
Expression
strain
Genetic modificationsa Extra sequences PDB
Accession
Code and
reference
Orai Calcium release
activated
channel (CRAC)
Drosophila
melanogaster
pPICZ SMD1163 N and C terminally
truncated. Mutated to
facilitate crystallisation
and reduce formation of
non-specific disulphide
bonds
C-terminal
antitubulin antibody
affinity tag
4HKR, [23]
Aquaporins
AQP2 Aquaporin Homo sapiens pPICZ GS115
aqy-1D
Codon optimised
C-terminally truncated
N-terminal 8 His
tag followed by a
TEV protease
cleavage site
4NEF, [15]
AQP4 Aquaporin Homo sapiens pPICZ X-33 N-terminal 8His
tag followed by a
FLAG tag and a 3C
protease cleavage
site
3GD8, [59]
AQP5 Aquaporin Homo sapiens pPICZ X-33 No tags 3D9S, [36]
SoPIP2;1 aquaporin Spinacia oleracea pPICZ X-33 C-terminal c-myc tag
followed by a 6His
tag
1Z98, 2B5F,
[35]
SoPIP2;1 aquaporin Spinacia oleracea pPICZ X-33 N-terminal 6His tag
followed by a
Thrombin protease
cleavage site except
for double mutant
3CN5
3CLL, 3CN5,
3CN6, [60]
Transporters
P-glycoprotein Mus musculus pHIL-D2 GS115 Mutated to remove
N-linked
glycosylation sites
C-terminal 6 His tag 3G5U, [42];
4MIM, [61]
(structure
refined from
original data)
P-glycoprotein Mus musculus pLIC KM71H Mutated to remove
N-linked glycosylation
sites and codon
optimised
C-terminal 6 His tag 4K5B, 4K5C,
4K5D, [19]
P-glycoprotein Caenorhabditis
elegans
pPICZ SMD1163 C-terminal
PreScission
protease cleavage
site followed by GFP
and a 10 His tag
4F4C, [27]
CmABCB1
(P-glycoprotein
homologue)
Cyanidioschyzon
merolae
pPICZ SMD1163 C-terminal TEV
protease
cleavage + 10 His
tag
(GSENLYFQGRSH10) 3WME, [62]
a Only modifications made to facilitate expression, purification and/or crystallisation are included here, not mutations made to explore protein
function.
b SB Long (unpublished data).copy number does not necessarily correlate with higher
target protein expression so it is not usually sufficient to
identify clones based on copy number alone, ideally func-
tional protein expression levels must also be assessed [9].
One important feature of the P. pastoris system is that it is
highly suitable for large scale growth and culture using
bioreactors [10]. Bioreactors give the user precise control
over culture parameters including pH, aeration, feed rate
and temperature as well as allowing real-time monitoring ofwww.sciencedirect.com changes in OD600 and dissolved oxygen [11]. This allows
tightly regulated growth of the culture and means that
ultra-high cell densities (>100 g/L dry cell weight;
>500 OD600 units/mL) can be achieved [10
]. Medium
density cultures (100 OD600 units/mL) are more usual for
membrane proteins since this both reduces proteolysis [12]
and cellular stress [13] associated with high density cul-
tures. This feature combined with comparatively inexpen-
sive growth medium makes P. pastoris a highly efficient
and cost-effective expression system.Current Opinion in Structural Biology 2015, 32:9–17
12 New constructs and expressions of proteins
Figure 1
Multiple Cloning Sites
pPIC9K
9.3 kb
(a) (b) (c)
(d) (e) (f) (g) 188
62
49
38
28
40
30
20
10
0
Sp
ec
ific
 [
H
] Z
M2
41
38
5 b
ind
ing
(pm
ol/
mg
)
Colonies
(h)
(SMD1163)
5’A
OX1 S TT
H
IS4
Am
pi
cil
in
pBR322
3
’AOX1 Kanamyc
in
∗
Current Opinion in Structural Biology
Schematic illustrating the key steps in expression of an integral membrane protein in the methylotrophic yeast, P. pastoris. E. coli is typically used
for construct generation and amplification (a). Following confirmation of the correct sequence (b), the expression vector containing the gene of
interest together with appropriate tags and protease cleavage sites is transformed into electrocompetent P. pastoris cells (c). The DNA is
linearised before transformation and so integrates into the host vector. In our laboratory all our research involved the SMD1163 protease deficient
strain. Depending on the expression vector and cell line combination used initial selection of the colonies can be done using antibiotics (e.g.
zeocin) or (d) auxotrophy of the strains. Colonies initially selected using cell auxotrophy can then be further selected based on vector copy
number using increasing concentrations of the antibiotic G418 or zeocin (e). Although this indicates copy number it is not necessarily indicative of
the expression level of the target protein. Small scale expression trials can be carried out in 10–50 mL culture volume (f). Expression levels of the
target protein can be assessed using (g) functional analysis, Western blot analysis or direct fluorescence measurements where GFP is used as a
tag. Once the best expressing clone is identified this can be used for large scale expression either in shaker flasks or bioreactors (h).A key consideration is that high levels of the methanol
used as an inducer are cytotoxic [14] which can reduce
culture viability and protein production. We use a sensor
to monitor levels of unmetabolised methanol in the
bioreactor [11] to reduce the potential risk of cytotoxic
effects and help to optimise protein expression levels.
Figure 1 summarises the steps involved in generating and
screening P. pastoris clones (see figure legend for details).Current Opinion in Structural Biology 2015, 32:9–17 Genetic modifications
There are several examples of membrane proteins suc-
cessfully produced in P. pastoris where the gene has been
modified to improve expression levels or facilitate crystal-
lisation (Table 1). Genes of interest are often codon
optimised for expression in P. pastoris [15,16,17]. It is
not clear in all cases what difference this makes to protein
production as a comparison with the non-codon optimised
gene is not always reported. However, a recent detailedwww.sciencedirect.com
Pichia pastoris and membrane protein expression Byrne 13study on P-glycoprotein (PgP) from mouse revealed that
expression from a gene codon optimised for P. pastoris
yielded substantially more protein than expression from
the wildtype gene [18]. Intriguingly, size exclusion anal-
ysis also revealed that the PgP expressed from the wildtype
gene codon was more aggregated than that expressed from
the codon optimised gene. These findings indicate that a
more stable protein is expressed from the codon optimisedFigure 2
(a) (b)
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(e) (f) (g
Examples of integral membrane protein structures obtained using protein ex
(Accession code: 4HKR). The protein is a homohexamer (individual monome
membrane. A bound Ba2+ ion is indicated in the red sphere. (b) GIRK2, G-p
homotetramer (individual monomers in blue and pink) and is shown looking
pore domain K+ channel K2P4.1 (Accession code: 3UM7). The protein is a d
the membrane. Associated K+ ions are indicated in red spheres. (d) Aquapo
(individual monomers in blue and pink) and is shown from the intracellular s
(Accession code: 3RZE). The protein is a monomer with the receptor shown
shown in the red spheres. (f) Monomamine oxidase B (Accession code: 1G
protein is normally located on the cytosolic side of the outer mitochondrial 
image. The bound flavin adenine dinucleotide is shown in yellow stick mode
Leukotriene synthase (Accession code: 2UUH). The protein is a trimer (indiv
located in the nuclear outer membrane and the protein is shown with the cy
code: 4F4C). The protein molecule is a single polypeptide chain comprised 
the glycosylation group shown in yellow stick model. The protein is shown 
www.sciencedirect.com gene. This construct has been subsequently used to obtain
high resolution structures of the PgP [19].
The GPCRs are typically truncated at the C-terminus.
This has been shown to increase both expression and
stability of the A2AR produced in P. pastoris [20] although
removal of this long flexible domain is also important for
crystallisation [21]. It is likely that for some GPCRs this(c)
Transporter
(d)
) (h)
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pressed in P. pastoris. (a) Orai Calcium release activated channel,
rs in blue and pink) and is shown from the extracellular side of the
rotein gated K+ channel (Accession code: 3SYO). The protein is a
 through the membrane. K+ ions are shown as red spheres. (c) Two
imer (individual monomers in blue and pink) and is shown parallel to
rin AQP2 (Accession code: 4NEF). The protein is a homotetramer
ide of the membrane. (e) Histamine H1–T4 lysozyme fusion protein
 in pink and the T4 lysozyme in blue. The bound ligand, doxepin, is
OS). The protein is a dimer (monomers shown in blue and pink). The
membrane and is shown with the cytosolic domains at the top of the
l and the inhibitor, pargyline, is shown in the red spheres. (g)
idual monomers in blue, pink and green). This protein is normally
tosolic domains at the top of the image. (h) P-glycoprotein (Accession
of two homologous domains (domains shown in blue and pink) with
looking through the membrane.
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14 New constructs and expressions of proteinsalso removes potential palmitoylation sites. The ion
channels, for example, the G-protein activated K+ chan-
nel [22] and the Orai Calcium release activated channel
[23], are also often truncated at both the N and C-termini
removing extended flexible regions to produce a compact
domain more suitable for crystallisation (see also Table 1
and Figure 2a,b). Identification of potential flexible
regions, which may hinder crystallisation can be carried
out using disorder prediction software such as RONN
[24].
Minor modifications include removal of N-linked glyco-
sylation sites through mutagenesis [16,17,25]. Removal
of these bulky, flexible groups is thought to be advanta-
geous for crystallisation. Yeast are able to glycosylate but
only perform some steps in common with higher eukar-
yotes, adding the core (Man)8-(GlcNAc)2 groups but not
the higher order decorations found in mammals. P. pas-
toris can hyper-glycosylate although to a lesser extent
than S. cerevisiae. A study by Yurugi-Kobayashi et al. [26]
expressed 25 non-glycosylated GPCRs in P. pastoris. The
data demonstrated that in many cases loss of glycosylation
resulted in reduced functional expression compared to
glycosylated receptor indicating that the effects of such
modifications need to be assessed for each individual
protein [26]. It was possible to obtain a high resolution
structure of a glycosylated form of P-glycoprotein (PgP)
[27] produced in P. pastoris demonstrating that at least in
some cases the presence of the sugar groups does not
inhibit the formation of well diffracting crystals
(Figure 2h).
Another reported modification mutates Cys residues to
prevent non-specific disulphide bridge formation which
could lead to loss of protein through aggregation [23,28].
Importantly, P. pastoris seems to be able to cope with
more radical genetic modifications including the expres-
sion of a Histamine H1 receptor–T4 lysozyme (H1R–
T4L) fusion protein [17]. Here the gene encoding
the T4L replaced the region of the H1R encoding the
third intracellular loop [29] (Figure 2e). This has the
overall effect of stabilising the receptor and also adding
an extended soluble domain, key in forming crystal con-
tacts essential for crystal growth. Interestingly, the initial
screening of the expression construct for the H1R–T4L
fusion protein was performed in S. cerevisiae [30]. The
final construct, which also incorporated a C-terminal TEV
cleavage site followed by GFP and a 10His tag, was
cloned directly from the S. cerevisiae vector into the
P. pastoris vector. The preferential use of S. cerevisiae
for screening is likely due to the ease of generating
constructs by homologous recombination [31] but clearly
P. pastoris was superior for large scale production pur-
poses. The ease of cloning from the S. cerevisiae vector to
the P. pastoris vector makes this two-step approach at-
tractive for a range of target proteins.Current Opinion in Structural Biology 2015, 32:9–17 Tagging the construct
Untagged membrane proteins have been successfully
isolated from P. pastoris culture [32–36] based on the
properties of the individual proteins (Figure 2f shows the
structure of one of these proteins, monoamine oxidase B).
However it is more usual to produce tagged versions of
the protein to facilitate both detection and isolation of the
target molecule. Expression in P. pastoris is compatible
with a range of different tags. The vast majority of
proteins have been expressed as His tagged constructs
(Table 1) to allow affinity chromatography. However
FLAG tags have also been used both for analysis of
the protein [37] and as a means of isolation [20]. A number
of protein constructs additionally incorporate GFP for
rapid assessment of optimal expression and solubilisation
conditions [28,38]. A range of different cleavage sites
have also been employed to successfully remove tags
before crystallisation trials (see Table 1 for details).
Some of the P. pastoris expression vectors used for heter-
ologous membrane protein expression incorporate the S.
cerevisiae alpha-mating factor sequence signal upstream of
the gene of interest facilitating correct protein targeting.
This has been shown to increase expression of the mouse
5-HT5A serotonin receptor [39] and the human m-opioid
receptor [40]. However presence of the alpha-mating
factor sequence signal dramatically reduced expression
of the Histamine H1 receptor [29]. Thus, screening is
essential to assess the effects of the addition of the signal
sequence. The alpha mating factor should be cleaved
following expression by the endogenous Kex2 protease.
However we have found that if recombinant expression
levels are very high then the Kex2 is unable to effectively
cleave the signal sequence from all the produced protein
leading to a heterogeneous population (Singh et al., un-
published data). Careful construct design incorporating a
proteolytic cleavage site upstream of the gene of interest
allowed us to deal with this issue [20]. Recent research has
produced a novel P. pastoris strain with increased Kex2
copy number which increases production of a secreted
protein [41]. Such a strain may also be suitable for
membrane protein production.
Expression strains
Compared to S. cerevisiae and E. coli, there are relatively
few expression strains available for P. pastoris. All the
strains that have been used for production of membrane
proteins share the methanol utilisation (Mut) pheno-
type. Most commonly P. pastoris cell strains produce
both the AOX1 and AOX2 proteins resulting in a wild-
type Mut+ methanol utilisation phenotype. However
the KM71 MutS strains contain only the less efficient
AOX2 protein and exhibit slow growth on methanol.
The wildtype X-33 strain, together with vectors allowing
antibiotic selection using Zeocin, was successfully used
to express the SoPIP2;1 aquaporin from spinach [35]. A
number of membrane proteins have been expressed inwww.sciencedirect.com
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encoding the histidinol dehydrogenase [32,42]. The
presence of this gene in the expression vector provides
a convenient means of screening for positive clones.
The SMD1163 strain (his4, pep4, prb1) lacks both Pro-
teinase A ( pep4) and Proteinase B ( prb1) activity. Pro-
teinase A activates endogenous P. pastoris proteases
including Proteinase B. However even in the absence
of Proteinase A, Proteinase B retains some activity. The
SMD1163 strain yielded increased expression of the 5-
HT5A serotonin receptor, a G-protein coupled receptor
(GPCR) compared to the GS115 strain [39]. This strain
is the most successful for the production of membrane
proteins for structural studies (Table 1) having been
utilised for the expression of GPCRs [17,21], ion
channels [16,22] and a transporter [27]. However, de-
spite the successes achieved using SMD1163 cells for
membrane protein production, it is important to note
that this strain is no longer commercially available. The
related SMD1168 strain (his4, ura3, pep4) lacks only
Proteinase A activity and is commercially available
but there are no examples of this strain being used to
successfully produce membrane proteins for structural
studies so it is difficult to assess its suitability.
A bespoke P. pastoris strain deficient in the native Aqua-
porin 1 was developed for structural studies on the yeast
aquaporin [43] and subsequently used for the production
of the human AQP2 aquaporin [15] (Figure 2d). Further,
more recent developments have resulted in a strain pro-
ducing cholesterol [44], and the rational identification of
the transcription factor, Hac1, co-expression of which may
facilitate membrane protein expression [45]. Although
neither approach has been utilised for protein production
for structural studies as yet, the addition of these to the
toolbox may widen the applicability of P. pastoris as an
expression host for challenging membrane proteins.
Optimisation of culture conditions
Optimisation  of membrane protein expression is possi-
ble through alteration of P. pastoris media components
and culture conditions. A range of different tempera-
tures (27–308C) have been used for initial culture
growth with a drop in temperature to 20–27 8C during
induction. However many manuscripts report no tem-
perature reduction for induction. The induction time is
also a key variable. An analysis of three different induc-
tion times 20, 40 or 60 hours indicated that 60 hours was
optimal for the production of human CHRM2, a GPCR,
in shaker flasks [26]. However optimal functional ex-
pression of the A2AR in a bioreactor was achieved after
only 18 hours [11]. Induction times of 16–60 hours have
been reported for a range of membrane proteins
[15,16,42] and although details are often not provided
it is inferred that these times were identified by opti-
misation trials as being the most suitable for the indi-
vidual target protein.www.sciencedirect.com Various additions to the media have been reported to
increase expression of GPCRs such as DMSO and Histi-
dine [7,46], although these have not been widely used.
Comparison with other systems for the
expression of membrane proteins
There have been a few studies specifically assessing a
range of different systems for the production of membrane
proteins for structural studies. Lundstrom et al. carried out a
study on over 100 GPCRs and showed that P. pastoris
successfully expressed as many individual receptors as a
Semliki Forest Virus mammalian cell system and produced
almost twice as many receptors as Escherichia coli [46].
Radioligand binding analysis also revealed that for several
of the receptors higher functional expression was achieved
in P. pastoris compared to the mammalian cell system
[46]. Comparison of muscarinic acetylcholine receptor
M2 expression in P. pastoris and Spodoptera frugipera insect
cells revealed similar levels of specific activity and binding
affinity but the higher cell densities achieved in P. pastoris
meant that the overall yield in this system was twice that in
the insect cells [47]. The most successful host for the
recombinant production of eukaryotic membrane proteins
for structural studies is currently the insect cell system [48],
however P. pastoris is not far behind.
What expression levels can be achieved?
Expression of both the human Aquaporin 1 (hAQP1) [49]
and the human adenosine A2A receptor (A2AR) in biore-
actor culture [11] produced more than twice the expres-
sion level achieved in the equivalent shaker flask culture.
In the case of the hAQP1 not only was there more protein
produced in the bioreactor but much more of it was
correctly localised to the membrane [49]. Western blot
analysis of the A2AR indicated that there was substantially
more receptor produced in the shaker flask than sug-
gested by functional analysis by radioligand binding assay
whilst the Western blot and binding assay results corre-
lated better for the bioreactor culture [11]. These results
show that the bioreactors produce not just higher amounts
of membrane protein but higher quality membrane pro-
tein. Isolation of the hAQP1 gave the remarkable yield of
90 mg/L. Yields of 13 mg/100 g cells are reported for the
codon optimised version of PgP expressed in a bioreactor
[18]. P. pastoris is a highly attractive system for produc-
tion of eukaryotic membrane proteins but successful
expression remains target protein dependent [50].
Conclusion
The low cost and high yields together with the eukaryotic
processing machinery mean P. pastoris is a viable alterna-
tive to insect and mammalian cell systems for the large
scale production of many integral membrane proteins for
structural studies. Whilst there remain no clear rules for
the successful expression of membrane proteins in P.
pastoris, the examples detailed here do provide a useful
set of guidelines for researchers. It is also anticipated thatCurrent Opinion in Structural Biology 2015, 32:9–17
16 New constructs and expressions of proteinsa more expanded set of expression vectors and cell strains
will greatly facilitate the production of more challenging
membrane proteins in the future.
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